Corporate News

EAACI Hybrid Congress 2022

July 2022

INMUNOTEK has participated in the commercial exhibition of the annual EAACI congress held in Prague (Czech Republic) on 1-3 July. Although it has also been held in hybrid form and hampered by the mobility restrictions that still exist in many countries, it has had a large number of attendees.
More info

50 Most Admired Companies to Watch 2022

April 2022

INMUNOTEK featured in CIO Bulletin's "50 Most Admired Companies to Watch 2022" list after being nominated for its business performance based on innovative and competitive products in the allergy and immunology fields.
More info

CIEGE 2021 Seal for Business Excellence

Sello IeEDecember 2021

INMUNOTEK obtains the CIEGE Seal for excellence in business management for the third consecutive year granted by Informa-ElEconomista. This Seal certifies excellent management over 57 indicators from 10 categories: solvency, profitability, growth, employment, internationalization, corporate social responsibility, customer satisfaction, innovation, commercial risk management and digitization.
More info

INMUNOTEK listed in CEPYME500 - 2021

November 2021

INMUNOTEK has once again been awarded the CEPYME500 seal in its 2021 edition, which recognizes the 500 leading Spanish companies in business growth, both for their results and their ability to generate added value, employment, innovation and international projection. This is the third year that INMUNOTEK has received this distinguished seal.
More info

INMUNOTEK, new CEOE member

November 2021

INMUNOTEK joins the CEOE as an associated member. This organization, which represents and defends the interests of Spanish companies, integrates most of the companies based in Spain, through different sectorial organizations or independently associated.
More info